Neutropenia in Human Immunodeficiency Virus Infection
Author(s) -
Alexandra M. Levine,
Roksana Karim,
Wendy J. Mack,
D. Jay Gravink,
Katherine Anastos,
Mary Young,
Mardge H. Cohen,
Meg D. Newman,
Michael Augenbraun,
Stephen J. Gange,
D. Heather Watts
Publication year - 2006
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.166.4.405
Subject(s) - neutropenia , absolute neutrophil count , medicine , zidovudine , immunology , lymphocyte , human immunodeficiency virus (hiv) , gastroenterology , viral disease , chemotherapy
Neutropenia is well described in individuals infected with human immunodeficiency virus (HIV) and occurs in approximately 10% to 50% of cases. Neither the effect of highly active antiretroviral therapy (HAART) on neutrophil counts nor the significance of neutropenia in terms of survival has previously been evaluated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom